Study to Evaluate HT-4253 in Healthy Subjects

Clinical trial NCT06537817 · COMPLETED

Trial details

NCT number: NCT06537817
Sponsor: Halia Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Normal Healthy Subjects

Start date: 2024-09-17
Primary completion: 2025-05-12
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.